Lee Ainslie’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Sell
98,098
-46,359
-32% -$1.07M 0.02% 69
2026
Q1
$3.46M Buy
144,457
+37,864
+36% +$926K 0.04% 67
2025
Q4
$2.41M Buy
106,593
+75,278
+240% +$1.64M 0.03% 129
2025
Q3
$631K Buy
+31,315
New +$525K 0.01% 200
2024
Q2
Sell
-23,813
Closed -$388K 335
2024
Q1
$388K Buy
+23,813
New +$372K 0.01% 281
2022
Q1
Sell
-2,329
Closed -$66K 281
2021
Q4
$66K Sell
2,329
-12,131
-84% -$377K ﹤0.01% 283
2021
Q3
$461K Buy
+14,460
New +$485K ﹤0.01% 445
2021
Q2
Sell
-1,717,913
Closed -$50.6M 723
2021
Q1
$50.6M Buy
1,717,913
+1,707,673
+16,676% +$52.5M 0.47% 35
2020
Q4
$314K Buy
+10,240
New +$312K 0.01% 450

Other funds holding ELAN

Lee Ainslie's ELAN Position: Q2 2026 in Review

Lee Ainslie reduced its Elanco Animal Health (ELAN) stake by 32% in Q2 2026, selling an estimated $1.07M and leaving 98,098 shares worth $2.41M. The position accounts for 0.02% of the portfolio, ranked #69.

Lee Ainslie first reported a position in ELAN in Q4 2020 and has held it in 9 quarters since. The position peaked at $50.6M in Q1 2021. 517 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Lee Ainslie held 98,098 shares of Elanco Animal Health worth $2.41M as of Q2 2026.
  • Lee Ainslie sold 46,359 Elanco Animal Health shares in Q2 2026, an estimated $1.07M.
  • Elanco Animal Health made up 0.02% of Lee Ainslie's portfolio in Q2 2026, its #69 holding.
  • Lee Ainslie first reported a position in Elanco Animal Health in Q4 2020 and has held it in 9 quarters since.
  • Lee Ainslie's Elanco Animal Health position peaked at $50.6M in Q1 2021.
  • 517 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.